PubMed HealthSearch

PubMed · 8071826

Structure evolution of tablets during compression unloading.

Abstract

The evolution of internal structure within compacts composed of selected drugs and direct compression excipients, occurring during the unloading phase of compaction, was studied in an instrumented rotary tablet press. Utilizing three-dimensional viscoelastic analysis applied to successive, sequential segments of the unloading phase, elastic and viscous parameters were obtained that provide quantitative, incremental measures of the changing behavior of the compact during this period. It is apparent from these studies that the principal feature of this phase of compaction is the generation and propagation of internal fractures as a result of the release of internal stresses through expansion. The progression of elastic parameters from positive initial values to negative terminal values during unloading, coupled with the strong relationships they display to corresponding viscous parameters, supports this conclusion. These results follow well-established Dugdale fracture dynamics in which rate-dependent flow, occurring in the immediate surroundings of crack tips, accompanies crack formation and propagation. The extent of viscous flow depends both on the brittle versus plastic nature of the substance and on the extent of crack growth.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E G Rippie, W T Morehead. 1994. Structure evolution of tablets during compression unloading.. https://doi.org/10.1002/jps.2600830523

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Tolerance intervals for assessing individual bioequivalence.

Evaluation of equivalence of two formulations of a drug typically entails the comparison of average bioavailabilities. Recently, however, authors have become aware that this may be insufficient to assess individual bioequivalence, that is, interchangeability of formulations on an individual basis. This paper outlines a tolerance interval procedure to assess individual bioequivalence based on a model that includes a subject by formulation interaction. We give methods for several higher-order cross-over designs along with examples.

Chemistry, Pharmaceutical

Investigation of response factor ruggedness for the determination of drug impurities using high-performance liquid chromatography with ultraviolet detection.

Quantification of impurities in drug substances and dosage forms using HPLC assays with UV detection is often done by comparison to a standard of the drug itself. Depending on the spectra of the compounds involved, small changes in wavelength may cause response factors to vary from day to day and instrument to instrument. Lack of assay ruggedness with respect to wavelength can lead to poor reproducibility of results. Response factor ruggedness was investigated for potential impurities in LY297802 tartrate, a potent muscarinic agonist. The UV responses of some impurities at 280 nm, the analytical detection wavelength, differ from that of the parent and change significantly with small shifts in wavelength. The ruggedness of response factors was examined on a single detector and among several different detectors. Results varied significantly among the different detectors. The UV spectra of the impurities could be used to predict the effect of wavelength on ruggedness of response. A wavelength system suitability sample is proposed as a way to overcome variability due to small differences in detector wavelength.

Chemistry, Pharmaceutical